[1] 沈洁,郑莹.中国实现全球消除宫颈癌阶段性目标的研判.上海预防医学,2021,33:1196-1200. [2] Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin,2021,71:209-249. [3] 蔡玉群,万惠卿,郭巧珍,等.高危型人乳头瘤病毒感染作为宫颈癌初筛的价值分析.肿瘤防治研究,2015,42:610-613. [4] Curry SJ,Krist AH,Owens DK,et al.Screening for Cervical Cancer:US Preventive Services Task Force Recommendation Statement.JAMA,2018,320:674-686. [5] Sundström K,Elfström KM.Advances in cervical cancer prevention:Efficacy,effectiveness,elimination?.PLoS Med,2020,17:e1003035. [6] 张晓丽. 2015—2019年南通市通州区适龄妇女宫颈癌及乳腺癌筛查结果分析.中国初级卫生保健,2021,35:48-51. [7] 梁明斌,陆凤,方乐,等.浙江省农村试点地区妇女宫颈癌筛查结果及成本效果分析.中国肿瘤,2019,28:816-820. [8] Teng AM,Atkinson J,Disney G,et al.Changing socioeconomic inequalities in cancer incidence and mortality:Cohort study with 54 million person-years follow-up 1981-2011.Int J Cancer,2017,140:1306-1316. [9] Lundqvist A,Andersson E,Ahlberg I,et al.Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis.Eur J Public Health,2016,26:804-813. [10] 程琳,张琨,许天敏.预防性HPV 疫苗的临床应用进展及思考.现代肿瘤医学,2017,25:328-331. [11] 汪辉. 公众医学素养缺失与医患纠纷研究.硕士.安徽医科大学,2015. [12] 司楠. 新时期我国科普工作的对策研究.硕士.郑州大学,2011. [13] Gultekin M,Ramirez PT,Broutet N,et al.World Health Organization call for action to eliminate cervical cancer globally.Int J Gynecol Cancer,2020,30:426-427. [14] Warwick J,Tabàr L,Vitak B,et al.Time-dependent effects on survival in breast carcinoma:results of 20 years of follow-up from the Swedish Two-County Study.Cancer,2004,100:1331-1336. [15] Sankaranarayanan R,Esmy PO,Rajkumar R,et al.Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu,India:a cluster-randomised trial.Lancet,2007,370:398-406. [16] 苗卫军,刘燕清,许咏怡,等.我国医学科普传播现状分析与对策研究.中国医疗前沿(下半月),2011,6:88-89. [17] 姜联合,袁志宁,马强.发达国家和我国科技计划项目科普化现状比较.科普研究,2010,5:39-47. [18] 子宫肌瘤的诊治中国专家共识专家组.子宫肌瘤的诊治中国专家共识.中华妇产科杂志,2017,52:793-800. [19] 刘文敏,付振明.宫颈癌预防与筛查研究进展.中国预防医学杂志,2022,23:713-720.
